Skip to main content
SpringerLink
Log in

Cancers des voies biliaires

  • Chapter
Les cancers digestifs

Part of the book series: Oncologie Pratique ((ONCOLPRAT))

  • 316 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Khan SA, Davidson BR, Goldin R et al. (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document Gut S1(Suppl VI): VI1–VI9

    Google Scholar 

  2. De Groen PC, Gores GJ, LaRusso NF et al. (1999) Biliary tract cancer N Engl J Med 41: 1368–78

    Google Scholar 

  3. Kang YK, Jang JJ (2002) Expression of G1-S modulators (p53, p16, p27, cyclin D,1Rb) and smad 4/Dpc 4in intrahepatic cholangiocarcinome Hum Pathol 33: 877–83

    Article  CAS  PubMed  Google Scholar 

  4. Aishima SI, Taguchi KI, Sugimachi K et al. (2002) c-erbB-2 and c-Met expression relates to cholangiocarcinogensesis and progression of intra hepatic cholangiocarcinome Histopathology 40: 269–78

    Article  PubMed  Google Scholar 

  5. Mikami T, Sagusa M, Mitomi H et al. (2001) Significant correlation of E-cadherin, catenin and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas Am J Clin Pathol 116: 369–76

    CAS  PubMed  Google Scholar 

  6. Kawarada Y, Ymagiwa K, Das BC (2002) Analysis of relationship between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma Am J Surg 183: 679–85

    Article  PubMed  Google Scholar 

  7. Hoang MP, Murakata LA, Katabi N et al. (2002) Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases. Mod Pathol 15: 1251–8

    PubMed  Google Scholar 

  8. Rullier A, Le Bail B, Fawaz R et al. (2000) Cytokeratine 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol 24: 870–6

    Article  CAS  PubMed  Google Scholar 

  9. Tickoo SK, Zee SY, Obiewke S et al. (2002) Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical and in situ hybridisation study, Am J Surg Pathol 26: 989–97

    Article  PubMed  Google Scholar 

  10. Kayahara M, Nagakawa T, Ohta T et al. (1999) Role of nodal involvment and the periductal soft-tissue margin in middle and distal bile duct cancer. Ann Surg 229: 76–83

    Article  CAS  PubMed  Google Scholar 

  11. Jarnagin WR, Fong Y, Dematteo R et al. (2001) Staging, resectability and outcome in 225 patients with hilar cholangiocarcinoma Ann Surg 234: 507–19

    Article  CAS  PubMed  Google Scholar 

  12. Suzuki S, Sakaguchi T, Yokoi Y et al. (2002) Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg 26: 687–93

    Article  PubMed  Google Scholar 

  13. Munoz L, Roayaie S, Maman D et al. (2002) Hilar cholangiocarcinoma involving the portal vein bifurcation: long term results after resection J Hepatobiliary Pancreat Surg 9: 237–41

    PubMed  Google Scholar 

  14. Capussotti L, Muratore A, Polastri R et al. (2002) Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival J Am Coll Surg 5: 713–8

    Google Scholar 

  15. Yamaguchi R, Nagino M, Oda K et al. (2002) Perineural invasion has a negative impact on survival of patients with gallbladder carcinoma, Br J Surg 89: 1130–6

    Article  CAS  PubMed  Google Scholar 

  16. Ramage JK, Donaghy A, Farrant JM et al. (1995) Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology108: 865–9

    Article  CAS  PubMed  Google Scholar 

  17. Siqueira E, Schoen RE, Silverman W et al. (2002) Detecting cholangiocarcinoma in patients with primary sclerosing cholangites. Gastrointes Endosc 56: 40–7

    Google Scholar 

  18. Zidi SH, Prat F, Le Guen O et al. (2000) Performance choracteristics of magnetic resonance cholangiographie in the staging of malignant hilar strictures. Gut 46: 103–6

    Article  CAS  PubMed  Google Scholar 

  19. Materne R, Van Beers BE, Gigot JF et al. (2000) Extrahepatic biliary obstruction: magnetic resonance imaging compared with endoscopic ultrasonography. Endoscopy 32: 3–9

    Article  CAS  PubMed  Google Scholar 

  20. Mandsfield JC, Griffin SM, Waderha V, Matthewson K (1997) A prospective evaluation of cytology from biliary strictures. Gut 40: 671–7

    Google Scholar 

  21. Kluge R, Schmidt F, Caca K et al. (2001) Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 33: 1029–35

    Article  CAS  PubMed  Google Scholar 

  22. Kato T, Tsukamoto E, Kuge Y et al. (2002) Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging 29: 1047–54

    CAS  PubMed  Google Scholar 

  23. Johnson SR, Kelly BS, Pennington LJ, Hanto DW (2001) A single center experience with extrahepatic cholangiocarcinomes. Surgery 130: 484–92

    Article  Google Scholar 

  24. Hirohashi K, Uenishi T, Kubo S et al. (2002) Histologic bile duct invasion by a massforming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 9: 233–6

    Article  PubMed  Google Scholar 

  25. Ebata T, Watanabe H, Ajioka Y et al. (2002) Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg 89: 1260–7

    Article  CAS  PubMed  Google Scholar 

  26. Abdalla EK, Barnett CC, Doherty D et al. (2002) Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolisation. Arch Surg 137: 675–80

    PubMed  Google Scholar 

  27. Slakey DP (2002) Radiofrequency ablation of recurrent cholangiocarcinoma. Am Surg 68: 395–7

    PubMed  Google Scholar 

  28. Launois B, Cubertafond P (1988) Les cancers des voies biliaires. Rapport présenté au 90e Congrés français de chirurgie. Monographies de l’association française de chirurgie, Masson

    Google Scholar 

  29. De Vreede I, Steers JL, Burch PA et al. (2000) Prolonged disease-free survival after orthoptic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl. 6: 309–16

    PubMed  Google Scholar 

  30. Takada T, Amano H, Yasuda H et al. (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95: 1685–95

    PubMed  Google Scholar 

  31. Hochwald SN, Burke EC, Jarnagin WR et al. (1999) Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 134: 261–6

    CAS  PubMed  Google Scholar 

  32. Sewnath ME, Karsten TM, Prins MH et al. (2002) A meta-analysis of pre-operative biliary drainage for tumors causing obstructive jaundice Ann Surg 236: 17–27

    Article  PubMed  Google Scholar 

  33. Cheng JL, Bruno MJ, Bergman JJ et al. (2002) Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic wallstents. Gastrointest Endoscp 56: 33–9

    Google Scholar 

  34. Pinol V, Castells A, Bordas JM et al. (2002) Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprotheses for treating malignant biliary obstruction: randomized clinical trial Radiology 225: 27–34

    PubMed  Google Scholar 

  35. Glimelius B, Hoffman K, Sjöden PO et al. (1996) Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 7: 593–600

    CAS  PubMed  Google Scholar 

  36. Mezger J, Sauerbruch T, Ko Y, Wolter H (1997) Phase II of gemcitabine (GEM) in biliairy tract cancers (BTC) Proc Am Soc Clin Oncol 16: A 1059

    Google Scholar 

  37. Ducreux M, Van Cutsem E, Van Laethem JL et al. (2005) A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial. Eur J Cancer 41: 398–403

    Article  CAS  PubMed  Google Scholar 

  38. Rougier P, Fandi A, Ducreux M (1995) Demonstrated efficciency of 5-fluorouracil contiuous infusion and cisplatin in patients with adavanced biliary tract carcinoma. Proc Am Soc Clin Oncol 14: A 205

    Google Scholar 

  39. Taieb J, Mitry E, Artru P et al. (2002) Optimization of 5-fluorouracile (5-FU)/cisplatine combination chemotherapy with a schedule of leucovorin, 5-FU and cisplatin (LV5-FU-P regimen) in patients with biliary tract carcinoma. Ann Oncol 13: 1192–6

    Article  CAS  PubMed  Google Scholar 

  40. Nehls O, Klump B, Arkenau HT et al. (2002) Oxaliplatin, fluororuacil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial. Br J Cancer 87: 702–4

    Article  CAS  PubMed  Google Scholar 

  41. Crane CH, Mac-Donald KO, Vauthey JN et al. (2002) Limitations of conventionnal doses of chemoradiation for unresectable biliary cancer. Int J radiat Oncol Biol Phys 53: 969–74

    Article  PubMed  Google Scholar 

  42. Bowling TE, Galbraith SM, Hatfield ARW et al. (1996) A retrospective comparaison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut 39: 852–5

    CAS  PubMed  Google Scholar 

  43. Kim S, Kim SW, Bang YJ et al. (2002) Role of post-opérative radiotherapy in the management of extra-hepatic bile duct cancer. Int J Oncol Biol Phys 54: 414–9

    Google Scholar 

  44. Ducreux M, Lusinchi A (1997) La radiothérapie et la chimiothérapie dans le traitement des cancers primitifs des voies biliaires. Hépato-Gastro 4: 449–52

    Google Scholar 

  45. Dobelbower RR, Merrick HW, Ahuja RK, Skeel RT (1986) 125I interstitial implant, precision high dose external beam therapy, and 5-FU for unresectable adenocarcinoma of pancreas and extrahepatic biliary tree Cancer 58: 2185–95

    PubMed  Google Scholar 

  46. Wiedmann M., Caca K., Berr F et al. (2003) Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma Cancer 97: 2783–90

    Article  PubMed  Google Scholar 

  47. Dumoulin FL, Gerhardt T, Fuchs S et al. (2003) Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma Gastrointest Endosc 57: 860–7

    Article  PubMed  Google Scholar 

  48. Ducreux M, Maingon P (2003) Cancer des voies biliaires. In: Que faire devant un cancer digestif en 2003 ? http://www.u-bourgogne.fr/FFCD/index.htm

    Google Scholar 

Download references

Authors
  1. J. Ezenfis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag France

About this chapter

Cite this chapter

Ezenfis, J. (2006). Cancers des voies biliaires. In: Les cancers digestifs. Oncologie Pratique. Springer, Paris. https://doi.org/10.1007/2-287-30874-1_10

Download citation

  • DOI: https://doi.org/10.1007/2-287-30874-1_10

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-22087-6

  • Online ISBN: 978-2-287-30874-1

Publish with us

Policies and ethics

Search

Navigation